1-7 of 7
Fátima Al-Shahrour
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dianhydrogalactitol Overcomes Multiple Temozolomide Resistance Mechanisms in Glioblastoma

Available to Purchase
Miguel Jiménez-Alcázar, Álvaro Curiel-García, Paula Nogales, Javier Perales-Patón, Alberto J. Schuhmacher, Marcos Galán-Ganga, Lucía Zhu, Scott W. Lowe, Fátima Al-Shahrour, Massimo Squatrito
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (6): 1029–1038.
https://doi.org/10.1158/1535-7163.MCT-20-0319
Published: 01 June 2021
View articletitled, Dianhydrogalactitol Overcomes Multiple Temozolomide Resistance Mechanisms in Glioblastoma
Open the PDF for Dianhydrogalactitol Overcomes Multiple Temozolomide Resistance Mechanisms in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells

Available to Purchase
Spas Dimitrov-Markov, Javier Perales-Patón, Bruno Bockorny, Ana Dopazo, Manuel Muñoz, Natalia Baños, Victoria Bonilla, Camino Menendez, Yolanda Duran, Ling Huang, Sofia Perea, Senthil K. Muthuswamy, Fatima Al-Shahrour, Pedro P. Lopez-Casas, Manuel Hidalgo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (8): 1751–1760.
https://doi.org/10.1158/1535-7163.MCT-19-1166
Published: 04 August 2020
View articletitled, Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells
Open the PDF for Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells in another window
Includes: Supplementary data
Journal Articles

Abstract B033: Transcriptional dissection and therapeutic modulation of metastasis development in pancreatic cancer

Free
Pedro P. Lopez-Casas, Spas Dimitrov, Javier Perales-Patón, Natalia Baños, Manuel Muñoz, Ana Dopazo, Fátima Al-Shahrour, Manuel Hidalgo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): B033.
https://doi.org/10.1158/1535-7163.TARG-17-B033
Published: 01 January 2018
View articletitled, Abstract B033: Transcriptional dissection and therapeutic modulation of metastasis development in pancreatic cancer
Journal Articles

Abstract LB-C21: CXCR7 expression is necessary for the maintenance of mesenchymal phenotype in acquired EGFR TKI resistance in NSCLC

Free
Jeffrey H. Becker, Yandi Gao, Ines Pulido, Eiki Kikuchi, Margaret Soucheray, Rutu Gandhi, Camilla L. Christensen, Fatima Al-shahrour, Kwok-Kin Wong, Julian Carretero, Takeshi Shimamura
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): LB-C21.
https://doi.org/10.1158/1535-7163.TARG-15-LB-C21
Published: 01 December 2015
View articletitled, Abstract LB-C21: CXCR7 expression is necessary for the maintenance of mesenchymal phenotype in acquired EGFR TKI resistance in NSCLC
Journal Articles

Abstract C75: Overcoming KRAS/LKB1 mutant NSCLC resistance to BET bromodomain inhibitors with gemcitabine or Mcl-1 inhibition

Free
Michael Kahle, Margaret Soucheray, Jeffrey Becker, Eiki Kikuchi, Inés Pulido, Esra Akbay, Camilla Christensen, Wei Qiu, Fatima Al-Shahrour, Neil Johnson, Julián Carretero, Kwok-Kin Wong, Takeshi Shimamura
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C75.
https://doi.org/10.1158/1535-7163.TARG-15-C75
Published: 01 December 2015
View articletitled, Abstract C75: Overcoming KRAS/LKB1 mutant NSCLC resistance to BET bromodomain inhibitors with gemcitabine or Mcl-1 inhibition
Journal Articles

Abstract A22: PanDrugsDB: Identifying druggable genetic dependencies for personalized cancer therapy

Free
Elena Piñeiro-Yáñez, Miguel Reboiro-Jato, Javier Perales-Patón, Daniel Glez-Peña, Héctor Tejero, Takeshi Shimamura, Julián Carretero, Alfonso Valencia, Manuel Hidalgo, Fátima Al-Shahrour
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A22.
https://doi.org/10.1158/1535-7163.TARG-15-A22
Published: 01 December 2015
View articletitled, Abstract A22: PanDrugsDB: Identifying druggable genetic dependencies for personalized cancer therapy
Journal Articles

Abstract A292: Salinomycin, an anti-cancer stem cell antibiotic, overcomes acquired resistance to BRAF inhibitors in BRAF-mutant human melanoma cell lines.

Free
Daniel Crespo, Ines Pulido, Maria L. Rodriguez, Salvador Aparisi, Alejandro Lopez, Margaret Soucheray, Fatima Al-Shahrour, Takeshi Shimamura, Angel Ortega, Julian Carretero
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A292.
https://doi.org/10.1158/1535-7163.TARG-13-A292
Published: 01 November 2013
View articletitled, Abstract A292: Salinomycin, an anti-cancer stem cell antibiotic, overcomes acquired resistance to BRAF inhibitors in BRAF-mutant human melanoma cell lines.